Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?

by Hayrapetyan, Armen , Khachatryan, Naira , Bastard, Mathieu , Guglielmetti, Lorenzo , Varaine, Francis , Huerga, Helena , Hovhannisyan, Lana , Yegiazaryan, Lusine , Faqirzai, Jamil , Hewison, Catherine

in Bacteriology / Clinical outcomes / Drug resistance / Effectiveness / Life Sciences / Microbiology and Parasitology / Multidrug resistant organisms / Statistical analysis / Tuberculosis

2018

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?

in Bacteriology / Clinical outcomes / Drug resistance / Effectiveness / Life Sciences / Microbiology and Parasitology / Multidrug resistant organisms / Statistical analysis / Tuberculosis

2018

Confirm

Do you wish to request the book?

Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?

in Bacteriology / Clinical outcomes / Drug resistance / Effectiveness / Life Sciences / Microbiology and Parasitology / Multidrug resistant organisms / Statistical analysis / Tuberculosis

2018

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?

Hayrapetyan, Armen,

Khachatryan, Naira,

Bastard, Mathieu,

Guglielmetti, Lorenzo,

Varaine, Francis,

Huerga, Helena,

Hovhannisyan, Lana,

Yegiazaryan, Lusine,

Faqirzai, Jamil,

Hewison, Catherine

2018

Overview

[...]long-term follow-up studies have shown that patients who have experienced previous treatment failure contribute importantly to ongoing transmission in the community (2). The study was approved by the relevant health authorities in Armenia and met the exemption criteria set by the MSF ethics review board for a posteriori analyses of routinely collected clinical data. The inverseprobability-weighted regression adjustment analysis showed that patients in the CU cohort had an estimated statistically significant increase in treatment success of 30.2% (95% confidence interval, 15.8-44.5%). [...]new and repurposed drugs can make fluoroquinoloneresistant MDR-TB, and potentially XDR-TB, a disease that is curable in the majority of cases.

Share this book

Add to My Shelf

Publisher

American Thoracic Society

Subject

/ Microbiology and Parasitology

/ Multidrug resistant organisms